MKSI · MKS Inc. · Stock research

Current Thesis

The two legs of this story, separated in the 2026-08-08 note, have now been tested against the cleanest possible read-across and the price leg failed. On 2026-08-13 Applied Materials — the biggest single tell-tale for MKS's Semiconductor segment, since MKS subsystems go into the same tool builds — posted record fiscal Q3 revenue of $9.12B (+25% YoY), non-GAAP EPS of $3.50 against $3.39 consensus, guided fiscal Q4 to roughly $10.25B ±$500M with non-GAAP EPS near $4.02, and raised its calendar-2026 outlook. MKSI made a lower leg into the following week, closing 2026-08-21 at $279.11 — under a dollar beneath the $280 May shelf identified two weeks earlier as the structural line — with RSI(14) at 38.8 and a three-month price change of -12.9%. The operating leg is unchanged and still accelerating: Q2 2026 revenue $1.248B and adjusted EPS $3.30 against $1.206B/$2.96 consensus, Q3 guided to $1.310–1.390B against a $1.243B Street, net leverage 3.0x on $188M of Q2 free cash flow. The narrative is saturated, dated by fourteen sell-side target actions since 2026-06-23 (five of them between 2026-08-07 and 2026-08-12) landing on a tape that is 37.3% below the $444.80 52-week high, and by a beat-and-raise on 2026-08-05 that closed down 4.49%. The label sits one confirmation away from dead: the shelf break is a single weekly close deep and shallow, so the structure is damaged, not yet demonstrably failed.

Bullish and bearish views on MKS Inc.

The model's bull view on MKS Inc. (MKSI), in brief: Q2 2026 print (2026-08-05): revenue $1.248B versus $1.206B consensus; adjusted EPS $3.30 versus $2.96 — above the $1.2B ±$40M guide given in May. The bear view: The most important datapoint of the last two weeks is a non-reaction: record numbers and a raised annual outlook from the sector's bellwether on 2026-08-13 did not stop MKSI from trading from the 2026-08-07 close of $304.99 down to $279.11 on 2026-08-21. Both cases follow in full.

Bull Case

• Q2 2026 print (2026-08-05): revenue $1.248B versus $1.206B consensus; adjusted EPS $3.30 versus $2.96 — above the $1.2B ±$40M guide given in May.
• Q3 2026 guide (2026-08-05): revenue $1.310–1.390B against $1.243B consensus, adjusted EPS $3.27–$3.89 against $3.18, GAAP EPS $2.42–$3.04 against $2.31. Midpoint above the Street on every line.
• End-market confirmation arrived after the last note: Applied Materials' 2026-08-13 release put fiscal Q3 revenue at a record $9.12B, +25% YoY, with fiscal Q4 guided to about $10.25B ±$500M and the calendar-2026 outlook raised on "strengthening demand and improved customer visibility." MKS's Q3 guide implies Semiconductor growth above 50% YoY (Q2 call, 2026-08-06) — the demand statement behind it has independent corroboration.
• Segment detail (Q2 call, 2026-08-06): Semiconductor +19% QoQ and +28% YoY; Electronics & Packaging +44% YoY with chemistry-equipment demand described as the strongest ever and visibility into 2027; Specialty Industrial +14% YoY, its highest since 2023. Chemistry revenue +21% YoY, AI-related chemistry running 15–20% of chemistry sales.
• Deleveraging is delivering: net leverage 3.0x, a full turn lower YoY, against a stated 2–2.5x target; $0.25/share quarterly dividend declared 2026-08-04, record 2026-08-25, payable 2026-09-03.
• Targets kept rising through the drawdown: Citi Buy $430 (2026-08-10, up from $425), J.P. Morgan Buy $380 (2026-08-11), Mizuho Buy $360 (2026-08-12), Cantor Fitzgerald Overweight $600 reiterated (2026-08-07). Consensus average sits at $413.62 across 13 analysts.

Bear Case

• The most important datapoint of the last two weeks is a non-reaction: record numbers and a raised annual outlook from the sector's bellwether on 2026-08-13 did not stop MKSI from trading from the 2026-08-07 close of $304.99 down to $279.11 on 2026-08-21. Good fundamental news has now failed twice in three weeks to produce a bid.
• The $280 May shelf gave way on a Friday close. Everything the June–July round-trip held is gone on a weekly measure.
• Goldman Sachs carries a Sell with a $270 target (raised from $265 on 2026-08-07) — a target beneath the last close, against a Cantor $600 at the other end. A $270-to-$600 dispersion on one set of numbers means the sell-side is arguing about the multiple, and the multiple is what the market is repricing.
• RSI(14) has slid from 45.5 on 2026-08-07 to 38.8 on 2026-08-21 without reaching a washed-out reading — momentum deterioration is ongoing rather than exhausted.
• Sector correlation drives the tape: peers Applied Materials, Lam Research and KLA all peaked 2026-06-30 and fell roughly 23%, 27% and 28% over the three weeks that followed; CNBC reported 2026-07-29 that chip stocks had shed more than $1 trillion. MKSI fell 3.2% on 2026-07-24 with no company-specific news, alongside AMAT, LRCX and SOXX.
• Net leverage at 3.0x against a 2–2.5x target leaves the equity levered to a cyclical revenue line, and a portion of the debt is euro-denominated after the €1.0B note offering of February 2026.
• Insider supply without offsetting demand: CEO John Lee sold 10,000 shares and CFO Ram Mayampurath 8,810 shares at $315.48 on 2026-05-22 under pre-planned programs, above where the shares now trade, with no disclosed open-market purchases since.

Setup & Price Structure

• Reference close 2026-08-21: $279.11, which is 37.3% below the $444.80 52-week high. Because 2026-08-21 was a Friday, that is also the weekly close, and it prints beneath the $280 shelf by less than a dollar.
• The depth of the break matters as much as the fact of it. A sub-1% penetration on one weekly bar is a marginal break; a second weekly close beneath it, or a failure to reclaim the 2026-08-07 close of $304.99, converts it into a structural one.
• Crowding observables, stated as observables: 13 analysts publish targets averaging $413.62, roughly 48% above the last close, and the ratings distribution is a Buy consensus with a single Sell at $270. Five target actions landed in the six sessions from 2026-08-07 to 2026-08-12 — the coverage cadence is dense while the price makes lower lows.
• No company earnings date inside the next 30 days; the next print is the ~November Q3 report. There is no scheduled company-specific event to force a repricing in either direction inside the window.
• No new Form 4 activity has surfaced in the recent filing window; the standing insider record is the 2026-05-22 10b5-1 executions at $315.48.

Catalyst Calendar (next 30 days)

• 2026-08-26 (after close) — NVIDIA fiscal Q2 2027 print, against its own guide of approximately $91.0B revenue. The single largest sentiment input for AI-capex-linked equipment and packaging names inside the window; MKS's Electronics & Packaging chemistry leg tracks AI server board and substrate builds.
• 2026-09-03 — Dividend payment date. Confirms cash return continues alongside the deleveraging programme rather than being suspended to fund debt paydown.
• ~2026-09-23 (est., unconfirmed) — Micron fiscal Q4 report, the cleanest public read on whether memory pricing is topping, which is one of the named drivers of the July–August WFE de-rating.
• ~2026-11-04 (est.) — Q3 2026 print, not yet scheduled. Outside the window, and the absence of anything company-specific before it is itself a structural fact about this setup.

Elapsed catalysts

• 2026-08-25 — Dividend record date for the $0.25/share payout declared 2026-08-04. Mechanical; listed so the small ex-date adjustment in the same window is not misread as further structural damage. (passed 1d ago)

What Would Change Our Mind

The structure has already given ground: the $280 shelf that anchored the prior read was lost on the weekly close of 2026-08-21 at $279.11. What decides whether that was noise or the start of the next leg is confirmation. A weekly close below $279 confirms the break and moves the life-cycle label from saturated to dead; a reclaim of the 2026-08-07 close of $304.99 on a weekly basis would say the break was a liquidity artefact rather than a change in the bid. On the fundamental side, the read fails if Q3 revenue lands under the $1.310B guide floor at the ~November print, or if net leverage sits at or above 3.0x with no voluntary prepayment disclosed — that removes the earnings kicker that converts EBITDA growth into the outsized EPS growth the $413.62 consensus target embeds. It improves if Semiconductor revenue grows sequentially again while the Electronics & Packaging visibility-into-2027 claim survives contact with a weaker WFE tape.

Correlation Notes

• Trades as a high-beta expression of the WFE complex: AMAT, LRCX, KLA and SOXX. The 2026-06-30 sector peak, the 2026-07-24 sympathy decline on no company news, and the 2026-08-13 record AMAT print that produced no lift together describe a name currently correlated to the sector's tape rather than its fundamentals.
• The Atotech chemistry leg links to AI server board and advanced-packaging substrate builds, so hyperscaler and NVIDIA capex commentary transmits faster than wafer-start data does.
• Memory: HBM and NAND layer-count roadmaps pull both subsystem and chemistry demand, making Micron and SK Hynix pricing disclosure a live input.
• FX: part of the capital structure is euro-denominated following the €1.0B note offering of February 2026, so EUR/USD moves the reported leverage line that the deleveraging story is graded on.